G1 Therapeutics (NASDAQ:GTHX) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
G1 Therapeutics reported in-line EPS of $-1.0 versus an estimate of $-1.0, which did not surprise analysts.
Revenue was up $21,741,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 3.35% drop in the share price the next day.
Here’s a look at G1 Therapeutics’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.97 | -1.07 | -0.87 | -0.30 |
| EPS Actual | -0.94 | -0.65 | -0.67 | -0.31 |
| Revenue Estimate | 2.59M | 770.00K | 4.06M | 28.57M |
| Revenue Actual | 6.60M | 14.22M | 16.55M | 26.60M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
